Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the outcomes of a trial investigating the use of a hydrogel spacer to hold the rectum away from the prostate during radiation therapy treatments.
Prostate Cancer
News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.
-
-
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and auto-contours them as the first step in creating radiation oncology treatment plans. This...
-
Leigh Conroy, Ph.D., physics resident, University Health Network, Princess Margaret Cancer Center, Toronto, Canada, explains how her center is using machine...
-
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company based in Oxford, U.K. Subject to customary closing conditions, completion of the transaction is expected in the third quarter of this calendar year.
-
This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data from numerous sources and then select medical records that are specific to a patient’s...
News | Clinical Trials | November 15, 2019
November 15, 2019 — Theragnostics, which is developing innovative...
News | Prostate Cancer | October 16, 2019
October 16, 2019 — GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.
Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage...
Videos | Prostate Cancer | September 30, 2019
Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the...
News | Brachytherapy Systems | September 13, 2019
September 13, 2019 — Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131...
Figure 1. 2-D (top) vs 3-D (bottom). The irregularly marginated left tumor mass that bulges the lateral capsule appears three times the volume on the multiplanar 3-D/4-D image reconstruction and shows complete extraprostatic extension. Note: This anterolateral lesion is not clinically palpable.
Feature | Prostate Cancer | September 05, 2019 | By Robert Bard, M.D., DABR, FASLM
Extracapsular extension (ECE) is a major clinical indicator for brachytherapy or external beam treatment of prostate...
News | Radiation Therapy | August 22, 2019
August 22, 2019 — As fiducial markers gain traction in parallel to rising incidences of various cancer affecting lung,...
Videos | Treatment Planning | August 21, 2019
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and...
News | Prostate Cancer | August 20, 2019
August 20, 2019 — According to the American Cancer Society, approximately...
News | Image Guided Radiation Therapy (IGRT) | August 19, 2019
August 19, 2019 — ViewRay Inc. announced the acceptance of publication by the International Journal of Radiation...
Technology | Interventional Radiology | August 16, 2019
August 16, 2019 — Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug...
News | Brachytherapy Systems | August 14, 2019
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medical...
News | Artificial Intelligence | July 26, 2019
July 26, 2019 — Oncology company Progenics Pharmaceuticals Inc. announced their collaboration with the Veterans Affairs...
Videos | Artificial Intelligence | July 22, 2019
Leigh Conroy, Ph.D., physics resident, University...
News | Radiopharmaceuticals and Tracers | July 01, 2019
July 1, 2019 — Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a...
News | Prostate Cancer | June 17, 2019
June 17, 2019 — A new study reveals black men are less likely than white men to adopt an active surveillance strategy...
The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.
News | Ultrasound Imaging | May 28, 2019
May 28, 2019 — Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make...
